Absolutely matt666.
As l posted last week PS is busy working on the split now. Too busy in fact to hold the R&D day he promised.
What is the urgency as until more positive results emerge from the trials any value assigned to the onco arm will have a substantial risk factor built in thus a lower value.
Result further dilution for us.
the attractivesness of acl, page-11
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable